Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages

被引:10
|
作者
Leymarie, Olivier [1 ,2 ,3 ]
Lepont, Leslie [1 ,2 ,3 ]
Versapuech, Margaux [1 ,2 ,3 ]
Judith, Delphine [1 ,2 ,3 ]
Abelanet, Sophie [1 ,2 ,3 ]
Janvier, Katy [1 ,2 ,3 ]
Berlioz-Torrent, Clarisse [1 ,2 ,3 ]
机构
[1] Inst Cochin, INSERM, U1016, Paris, France
[2] CNRS, UMR8104, Paris, France
[3] Univ Paris 05, Sorbonne Paris Cite, Paris, France
关键词
BST2/tetherin; VCC; Vpu; human immunodeficiency virus; macrophage; restriction factor; vesicular trafficking; viral release; HUMAN-IMMUNODEFICIENCY-VIRUS; RESTRICTION FACTOR; CELL-SURFACE; PLASMA-MEMBRANE; HIV-1; VPU; DOWN-REGULATION; INFECTION; RELEASE; TETHERIN; PROTEIN;
D O I
10.1128/JVI.00020-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-1 infection of macrophages leads to the sequestration of newly formed viruses in intracellular plasma membrane-connected structures termed virus-containing compartments (VCCs), where virions remain infectious and hidden from immune surveillance. The cellular restriction factor bone marrow stromal cell antigen 2 (BST2), which prevents HIV-1 dissemination by tethering budding viral particles at the plasma membrane, can be found in VCCs. The HIV-1 accessory protein Vpu counteracts the restriction factor BST2 by downregulating its expression and removing it from viral budding sites. Numerous studies described these Vpu countermeasures in CD4(+) T cells or model cell lines, but the interplay between Vpu and BST2 in VCC formation and HIV-1 production in macrophages is less explored. Here, we show that Vpu expression in HIV-1-infected macrophages enhances viral release. This effect is related to Vpu's ability to circumvent BST2 antiviral activity. We show that in absence of Vpu, BST2 is enriched in VCCs and colocalizes with capsid p24, whereas Vpu expression significantly reduces the presence of BST2 in these compartments. Furthermore, our data reveal that BST2 is dispensable for the formation of VCCs and that Vpu expression impacts the volume of these compartments. This Vpu activity partly depends on BST2 expression and requires the integrity of the Vpu transmembrane domain, the dileucine-like motif E59XXXLV64 and phosphoserines 52 and 56 of Vpu. Altogether, these results highlight that Vpu controls the volume of VCCs and promotes HIV-1 release from infected macrophages. IMPORTANCE HIV-1 infection of macrophages leads to the sequestration of newly formed viruses in virus-containing compartments (VCCs), where virions remain infectious and hidden from immune surveillance. The restriction factor BST2, which prevents HIV-1 dissemination by tethering budding viral particles, can be found in VCCs. The HIV-1 Vpu protein counteracts BST2. This study explores the interplay between Vpu and BST2 in the viral protein functions on HIV-1 release and viral particle sequestration in VCCs in macrophages. The results show that Vpu controls the volume of VCCs and favors viral particle release. These Vpu functions partly depend on Vpu's ability to antagonize BST2. This study highlights that the transmembrane domain of Vpu and two motifs of the Vpu cytoplasmic domain are required for these functions. These motifs were notably involved in the control of the volume of VCCs by Vpu but were dispensable for the prevention of the specific accumulation of BST2 in these structures.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Degranulation of Natural Killer Cells Following Interaction with HIV-1-Infected Cells Is Hindered by Downmodulation of NTB-A by Vpu
    Shah, Ankur H.
    Sowrirajan, Bharatwaj
    Davis, Zachary B.
    Ward, Jeffrey P.
    Campbell, Edward M.
    Planelles, Vicente
    Barker, Edward
    CELL HOST & MICROBE, 2010, 8 (05) : 397 - 409
  • [22] Impairment of phagosome-lysosome fusion in HIV-1-infected macrophages
    Moorjani, H
    Craddock, BP
    Morrison, SA
    Steigbigel, RT
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (01): : 18 - 22
  • [23] Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model
    Satou, Yorifumi
    Katsuya, Hiroo
    Fukuda, Asami
    Misawa, Naoko
    Ito, Jumpei
    Uchiyama, Yoshikazu
    Miyazato, Paola
    Islam, Saiful
    Fassati, Ariberto
    Melamed, Anat
    Bangham, Charles R. M.
    Koyanagi, Yoshio
    Sato, Kei
    SCIENTIFIC REPORTS, 2017, 7
  • [24] Healthy HIV-1-Infected Individuals on Highly Active Antiretroviral Therapy Harbor HIV-1 in Their Alveolar Macrophages
    Cribbs, Sushma K.
    Lennox, Jeffrey
    Caliendo, Angela M.
    Brown, Lou Ann
    Guidot, David M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (01) : 64 - 70
  • [25] Hepatitis B Virus Drug Resistance in HIV-1-Infected Patients Taking Lamivudine-Containing Antiretroviral Therapy
    Wongprasit, Pawinee
    Manosuthi, Weerawat
    Kiertiburanakul, Sasisopin
    Sungkanuparph, Somnuek
    AIDS PATIENT CARE AND STDS, 2010, 24 (04) : 205 - 209
  • [26] Long-term follow up of HIV-1-infected Korean haemophiliacs, after infection from a common source of virus
    Kim, B. -R.
    Kim, J. -E.
    Sung, H.
    Cho, Y. -K.
    HAEMOPHILIA, 2015, 21 (01) : E1 - E11
  • [27] The Landscape of IFN/ISG Signaling in HIV-1-Infected Macrophages and Its Possible Role in the HIV-1 Latency
    Rojas, Masyelly
    Luz-Crawford, Patricia
    Soto-Rifo, Ricardo
    Reyes-Cerpa, Sebastian
    Toro-Ascuy, Daniela
    CELLS, 2021, 10 (09)
  • [28] Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy
    Allen Ko
    Guobin Kang
    Julian B. Hattler
    Hadiza I. Galadima
    Junfeng Zhang
    Qingsheng Li
    Woong-Ki Kim
    Journal of Neuroimmune Pharmacology, 2019, 14 : 110 - 119
  • [29] Genetic Characterization of Natural Variants of Vpu from HIV-1 Infected Individuals from Northern India and Their Impact on Virus Release and Cell Death
    Verma, Sachin
    Ronsard, Larance
    Kapoor, Richa
    Banerjea, Akhil C.
    PLOS ONE, 2013, 8 (03):
  • [30] Differentially expressed genes in HIV-1-infected macrophages following treatment with the virus-suppressive immunomodulator murabutide
    Truong, MJ
    Delsart, W
    Bahr, GM
    VIRUS RESEARCH, 2004, 99 (01) : 25 - 33